Jounce Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/10/2023

Shares

15,404

Value ($000)

28

Weight

0.0%

2019 Q4 - 2023 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/10/2023	28	0.0%	15,404	3/31/2023
2022 Q3	11/10/2022	339	0.0%	144,885	9/30/2022
2022 Q2	8/5/2022	382	0.0%	126,073	6/30/2022
2022 Q1	5/12/2022	1,162	0.0%	171,124	3/31/2022
2021 Q4	2/10/2022	1,459	0.0%	174,738	12/31/2021
2021 Q3	11/12/2021	898	0.0%	120,898	9/30/2021
2021 Q2	8/12/2021	494	0.0%	72,596	6/30/2021
2021 Q1	5/13/2021	875	0.0%	85,195	3/31/2021
2020 Q4	2/16/2021	665	0.0%	94,929	12/31/2020
2020 Q3	11/12/2020	819	0.0%	100,386	9/30/2020
2020 Q2	8/13/2020	1,239	0.0%	179,564	6/30/2020
2020 Q1	5/13/2020	874	0.0%	184,088	3/31/2020
2019 Q4	2/12/2020	1,628	0.0%	186,488	12/31/2019